Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results (Q35849776)

From Wikidata
Revision as of 22:55, 24 July 2023 by KrBot (talk | contribs) (‎Set a claim value: author (P50): Brian Druker (Q373427), разрешение перенаправления / resolving redirect (Q38154974)Brian Druker (Q373427) (подробности / details))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article published on 7 March 2006
edit
Language Label Description Also known as
English
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
scientific article published on 7 March 2006

    Statements

    Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit